Currently, there are 215.98M common shares owned by the public and among those 186.09M shares have been available to trade.
The company’s stock has a 5-day price change of 4.03% and 473.57% over the past three months. IONQ shares are trading 206.46% year to date (YTD), with the 12-month market performance up to 192.75% higher. It has a 12-month low price of $6.22 and touched a high of $37.64 over the same period. IONQ has an average intraday trading volume of 20.22 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 26.07%, 91.46%, and 241.06% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of IonQ Inc (NYSE: IONQ) shares accounts for 35.41% of the company’s 215.98M shares outstanding.
It has a market capitalization of $8.68B and a beta (3y monthly) value of 2.49. The earnings-per-share (ttm) stands at -$0.82. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.66% over the week and 16.12% over the month.
Earnings per share for the fiscal year are expected to decrease by -7.98%, and -10.93% over the next financial year.
Looking at the support for the IONQ, a number of firms have released research notes about the stock. Craig Hallum stated their Buy rating for the stock in a research note on August 11, 2023, with the firm’s price target at $12-$21. Morgan Stanley coverage for the IonQ Inc (IONQ) stock in a research note released on April 26, 2023 offered a Equal-Weight rating with a price target of $7. Needham was of a view on June 08, 2022 that the stock is Buy, while Goldman gave the stock Neutral rating on November 22, 2021, issuing a price target of $28.
